ProfileGDS4718 / 65472_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 48% 74% 50% 62% 56% 48% 48% 55% 55% 49% 58% 44% 52% 43% 42% 64% 40% 51% 49% 48% 55% 55% 55% 53% 49% 62% 64% 54% 55% 53% 59% 53% 45% 56% 68% 34% 46% 54% 75% 47% 58% 48% 64% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4619149
GSM549102patient 115, normal, homogenized [OPG study]5.4293648
GSM549104patient 119, normal, homogenized [OPG study]7.3102774
GSM549108patient 138, normal, homogenized [OPG study]5.5702950
GSM549119patient 077, normal, homogenized [OPG study]6.2657662
GSM549133patient 032, cancer, homogenized [OPG study]5.8586456
GSM549139patient 042, cancer, homogenized [OPG study]5.3836548
GSM549099patient 107, normal, homogenized [OPG study]5.3980348
GSM549109patient 139, normal, homogenized [OPG study]5.8019555
GSM549110patient 046, normal, homogenized [OPG study]5.7760355
GSM549114patient 063, normal, homogenized [OPG study]5.3968649
GSM549122patient 082, normal, homogenized [OPG study]6.012458
GSM549134patient 033, cancer, homogenized [OPG study]5.1817544
GSM549136patient 036, cancer, homogenized [OPG study]5.5826452
GSM549140patient 044, cancer, homogenized [OPG study]5.0828543
GSM549111patient 047, normal, homogenized [OPG study]5.0853242
GSM549113patient 057, normal, homogenized [OPG study]6.4213664
GSM549132patient 031, cancer, homogenized [OPG study]4.9732640
GSM549137patient 038, cancer, homogenized [OPG study]5.5421751
GSM549142patient 047, cancer, homogenized [OPG study]5.598749
GSM549100patient 110, normal, homogenized [OPG study]5.4411948
GSM549107patient 135, normal, homogenized [OPG study]5.7818955
GSM549115patient 068, normal, homogenized [OPG study]5.7397355
GSM549116patient 072, normal, homogenized [OPG study]5.7821155
GSM549120patient 078, normal, homogenized [OPG study]5.6759653
GSM549131patient 030, cancer, homogenized [OPG study]5.4207849
GSM549118patient 074, normal, homogenized [OPG study]6.2352162
GSM549129patient 027, cancer, homogenized [OPG study]6.4585164
GSM549123patient 088, normal, homogenized [OPG study]5.7285754
GSM549124patient 006, cancer, homogenized [OPG study]5.8043955
GSM549126patient 015, cancer, homogenized [OPG study]5.687353
GSM549128patient 025, cancer, homogenized [OPG study]6.0438159
GSM549103patient 117, normal, homogenized [OPG study]5.7578253
GSM549117patient 073, normal, homogenized [OPG study]5.1927345
GSM549138patient 041, cancer, homogenized [OPG study]5.8485956
GSM549141patient 045, cancer, homogenized [OPG study]6.7695468
GSM549130patient 028, cancer, homogenized [OPG study]4.7105634
GSM549101patient 111, normal, homogenized [OPG study]5.3189446
GSM549105patient 128, normal, homogenized [OPG study]5.7753654
GSM549106patient 134, normal, homogenized [OPG study]7.4248175
GSM549112patient 048, normal, homogenized [OPG study]5.3477147
GSM549125patient 011, cancer, homogenized [OPG study]5.9777858
GSM549127patient 024, cancer, homogenized [OPG study]5.4370448
GSM549135patient 035, cancer, homogenized [OPG study]6.3930364